Artificial Intelligence is presently experiencing a renaissance in development of new methods and practical applications to ongoing challenges in Chemistry. This one day conference presents the current efforts in applying these new methods.
This is a timely event which will examine the unprecedented disruption and transformation of industries, business and the jobs market due to advancements in Artificial Intelligence and Virtual and Augmented Reality.
This conference will bring together key opinion leaders and senior industry experts to discuss the latest developments in drug discovery strategies, included Mark Davies, VP Bioinformatics at BenevolentAI.
Building Bridges in Medical Sciences is a one-day conference that brings together scientists from different disciplines, career stages and countries. The conference emphasises the need for interdisciplinary approaches to tackle the biomedical research and global health challenges of the 21st century.
Meet Jackie Hunter, CEO BenevolentBio and more than 500 healthcare, pharmaceutical and technology influencers and leaders at the fifth annual WIRED Health event in London.
Join Mark Rackham, Drug discovery scientist at BenevolentAI for a panel discussion on Precision Medicine and Biomarker Discovery
In 2016, total expenditure on prescription drugs in the US was estimated at $450 billion. During this year, almost half of the US population took at least one prescription medicine every month. It is essential that we find ways to streamline this process, removing inefficencies and unnecessary costs, while bringing efficacious prescription drugs to the population as soon as possible. We believe that Artificial Intelligence offers the best solutions to solve these issues.
The 5th annual Advanced Pharma Analytics Europe Summit 2018 is dedicated to bringing together Data Science and Advanced Analytics leaders to address the biggest challenges and opportunities in this space.
Join Ian Churcher, VP of Drug Discovery at BenevolentBio as he discusses Targeted Protein Degradation, one of the most exciting and fast growing areas of drug discovery. Ian will give an introduction to the area and highlight how AI approaches can be used to accelerate progress.
Jackie Hunter, CEO BenevolentAI is presenting at JP Morgan Healthcare Conference on the future of Pharma.
Join Jackie Hunter, CEO BenevolentBio who will share her thoughts and her experience.
Join Mark Davies, VP Biomedical Informatics at BenevolentAI for a talk on "Disrupting Drug Discovery with AI"
Join the conversation on "Looking into the Future – Bio-Innovation in 20 Years" at Innovation Forum with Jackie Hunter CEO, BenevolentBio.
We are delighted to announce that BenevolentAI is a sponsor at NIPS conference this year. Our team of data scientists and machine learning researchers will be present on booth 124 and we look forward to meeting you and talking AI, super computers and deep tech.
Join Nasrin Mostafazadeh at the NLP Seminar Series organised at Stanford University on the 30 November
Join Ken Mulvany Founder and Chairman of BenevolentAI for a talk on "Can a machine cure brain disease"
Join Jerome Pesenti, CEO BenevolentTech for a debate on Future challenges: preparing for Artificial Intelligence
Join Gareth Jones, VP Intellectual Property at BenevolentAI at the Future of Tech IP Summit
Join Rabia T. Khan, Exploratory Scientist at BenevolentAI for a panel discussion on What makes a great researcher: tools and skills.
Join Patrick Keohane, CMO at BenevolentAI for a panel on Disruption from Afar: Embracing New Non-Pharma Technologies & Actors
Jackie Hunter, CEO BenevolentBio and Jerome Pesenti, CEO BenevolentTech will be joining Web Summit this year.
Patrick Keohane, Chied Medical Officer at BenevolentBio will be presenting at the BioData World Congress 2017
Join Jerome Pesenti, CEO BenevolentTech at Founder Forum for a panel on Artificial Intelligence
Jerome Pesenti, CEO at BenevolentTech will be joining Data Driven Event held at Bloomberg LP to discuss how BenevolentAI artificial intelligence can accelerate drug discovery